OCT-A characterisation of recurrent type 3 macular neovascularisation.
Riccardo SacconiMarco BattistaEnrico BorrelliAlexandra MiereEleonora CorbelliVittorio CapuanoLea QuerquesEric H SouiedFrancesco Maria BandelloFrancesca AmorosoPublished in: The British journal of ophthalmology (2020)
Detectable flow deepening from the DVC to the RPE/sub-RPE space using OCT-A is mandatory to have a new exudation secondary to recurrent type 3 MNV. Early detection of type 3 MNV recurrence by OCT-A characterisation may prompt retreatment and potentially prevent progression to late stages of the disease.